dc.contributor.author | Grimolizzi, Franco | |
dc.contributor.author | Arranz, Lorena | |
dc.date.accessioned | 2019-02-05T10:11:24Z | |
dc.date.available | 2019-02-05T10:11:24Z | |
dc.date.issued | 2018-06-28 | |
dc.description.abstract | Succinate is an essential intermediate of the tricarboxylic acid cycle
that exerts pleiotropic roles beyond metabolism in both physiological and pathological conditions. Recent evidence obtained in mouse
models shows its essential role regulating blood cell function through various mechanisms that include pseudohypoxia responses by hypoxiainducible factor-1α activation, post-translational modifications like succinylation, and communication mediated by succinate receptor 1. Hence,
succinate links metabolism to processes like gene expression and intercellular communication. Interestingly, succinate plays key dual roles during
inflammatory responses, leading to net inflammation or anti-inflammation depending on factors like the cellular context. Here, we further discuss current suggestions of the possible contribution of succinate to blood
stem cell function and blood formation. Further study will be required in
the future to better understand succinate biology in blood cells. This
promising field may open new avenues to modulate inflammatory
responses and to preserve blood cell homeostasis in the clinical setting. | en_US |
dc.description.sponsorship | Northern Norway Regional Health Authority: ?
the University Hospital of Northern Norway (UNN): ?
UiT The Arctic University of Norway: (2014/5668)
The Norwegian Cancer Society: (6765150),
The Northern Norway Regional Health Authority: (HNF1338-17),
The Aakre-Stiftelsen Foundation: (2016/9050) | en_US |
dc.description | Source at: <a href=http://doi.org/10.3324/haematol.2018.196097>http://doi.org/10.3324/haematol.2018.196097</a>. Licensed <a href=http://creativecommons.org/licenses/by-nc-nd/4.0/> CC BY-NC-ND 4.0. </a> | en_US |
dc.identifier.citation | Grimolizzi, F. & Arranz, L. (2018). Multiple faces of succinate beyond metabolism in blood. <i>Haematologica, 103</i>(10), 1586-1592 | en_US |
dc.identifier.cristinID | FRIDAID 1622607 | |
dc.identifier.doi | 10.3324/haematol.2018.196097 | |
dc.identifier.issn | 0390-6078 | |
dc.identifier.issn | 1592-8721 | |
dc.identifier.uri | https://hdl.handle.net/10037/14610 | |
dc.language.iso | eng | en_US |
dc.publisher | Ferrata Storti Foundation | en_US |
dc.relation.journal | Haematologica | |
dc.relation.projectID | info:eu-repo/grantAgreement/RCN/EMBLNODE/187615/Norway/Norsk senter for molekylærmedisin (NCMM) - Centre for Molecular Medicine Norway - Nordic EMBL Partnership/NCMM/ | en_US |
dc.relation.projectID | info:eu-repo/grantAgreement/RCN/FRIMEDBIO/144182/Norway/Stem Cell Metabolic Dysfunction in Myeloid Leukaemia and its Therapeutic Targeting// | en_US |
dc.rights.accessRights | openAccess | en_US |
dc.subject | VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Hematology: 775 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Hematologi: 775 | en_US |
dc.title | Multiple faces of succinate beyond metabolism in blood | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |